{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:45:53Z","timestamp":1780623953183,"version":"3.54.1"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi221161-4\"><jats:title>Importance<\/jats:title><jats:p>Pregnant persons are at an increased risk of severe COVID-19 from SARS-CoV-2 infection, and COVID-19 vaccination is currently recommended during pregnancy.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221161-5\"><jats:title>Objective<\/jats:title><jats:p>To ascertain the association of vaccine type, time from vaccination, gestational age at delivery, and pregnancy complications with placental transfer of antibodies to SARS-CoV-2.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221161-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cohort study was conducted in Pennsylvania Hospital in Philadelphia, Pennsylvania, and included births at the study site between August 9, 2020, and April 25, 2021. Maternal and cord blood serum samples were available for antibody level measurements for maternal-neonatal dyads.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221161-7\"><jats:title>Exposures<\/jats:title><jats:p>SARS-CoV-2 infection vs COVID-19 vaccination.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221161-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>IgG antibodies to the receptor-binding domain of the SARS-CoV-2 spike protein were measured by quantitative enzyme-linked immunosorbent assay. Antibody concentrations and transplacental transfer ratios were measured after SARS-CoV-2 infection or receipt of COVID-19 vaccines.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221161-9\"><jats:title>Results<\/jats:title><jats:p>A total of 585 maternal-newborn dyads (median [IQR] maternal age, 31 [26-35] years; median [IQR] gestational age, 39 [38-40] weeks) with maternal IgG antibodies to SARS-CoV-2 detected at the time of delivery were included. IgG was detected in cord blood from 557 of 585 newborns (95.2%). Among 169 vaccinated persons without SARS-CoV-2 infection, the interval from first dose of vaccine to delivery ranged from 12 to 122 days. The geometric mean IgG level among 169 vaccine recipients was significantly higher than that measured in 408 persons after infection (33.88 [95% CI, 27.64-41.53] arbitrary U\/mL vs 2.80 [95% CI, 2.50-3.13] arbitrary U\/mL). Geometric mean IgG levels were higher after vaccination with the mRNA-1273 (Moderna) vaccine compared with the BNT162b2 (Pfizer\/BioNTech) vaccine (53.74 [95% CI, 40.49-71.33] arbitrary U\/mL vs 25.45 [95% CI, 19.17-33.79] arbitrary U\/mL; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). Placental transfer ratios were lower after vaccination compared with after infection (0.80 [95% CI, 0.68-0.93] vs 1.06 [95% CI, 0.98-1.14]; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) but were similar between the mRNA vaccines (mRNA-1273: 0.70 [95% CI, 0.55-0.90]; BNT162b2: 0.85 [95% CI, 0.69-1.06]; <jats:italic>P<\/jats:italic>\u2009=\u2009.25). Time from infection or vaccination to delivery was associated with transfer ratio in models that included gestational age at delivery and maternal hypertensive disorders, diabetes, and obesity. Placental antibody transfer was detectable as early as 26 weeks\u2019 gestation. Transfer ratio that was higher than 1.0 was present for 48 of 51 (94.1%) births at 36 weeks\u2019 gestation or later by 8 weeks after vaccination.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221161-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This study found that maternal and cord blood IgG antibody levels were higher after COVID-19 vaccination compared with after SARS-CoV-2 infection, with slightly lower placental transfer ratios after vaccination than after infection. The findings suggest that time from infection or vaccination to delivery was the most important factor in transfer efficiency.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.40993","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T16:01:46Z","timestamp":1668009706000},"page":"e2240993","source":"Crossref","is-referenced-by-count":35,"title":["Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection"],"prefix":"10.1001","volume":"5","author":[{"given":"Dustin D.","family":"Flannery","sequence":"first","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Clinical Futures, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Gouma","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren B.","family":"Dhudasia","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Clinical Futures, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagori","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Clinical Futures, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline R.","family":"Pfeifer","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Woodford","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Briker","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jourdan E.","family":"Triebwasser","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Gerber","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Clinical Futures, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Division of Infectious Diseases, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison E.","family":"Weirick","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"McAllister","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Hensley","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Puopolo","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Clinical Futures, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"issue":"44","key":"zoi221161r1","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.15585\/mmwr.mm6944e3","article-title":"Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status\u2014United States, January 22-October 3, 2020.","volume":"69","author":"Zambrano","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"zoi221161r2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamapediatrics.2021.1050","article-title":"Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational cohort study.","volume":"175","author":"Villar","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"5","key":"zoi221161r3","doi-asserted-by":"publisher","first-page":"522.e1","DOI":"10.1016\/j.ajog.2021.05.016","article-title":"Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study.","volume":"225","author":"Gurol-Urganci","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"zoi221161r4","doi-asserted-by":"publisher","first-page":"e570","DOI":"10.1542\/neo.22-9-e570","article-title":"Vaccination of pregnant women against COVID-19.","volume":"22","author":"Abu-Raya","year":"2021","journal-title":"Neoreviews"},{"issue":"4","key":"zoi221161r5","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.vaccine.2020.11.078","article-title":"Epidemiology of COVID-19 infection in young children under five years: a systematic review and meta-analysis.","volume":"39","author":"Bhuiyan","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"zoi221161r6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13256-020-02519-1","article-title":"Death of a neonate with suspected coronavirus disease 2019 born to a mother with Coronavirus Disease 2019 in Iran: a case report.","volume":"14","author":"Rashidian","year":"2020","journal-title":"J Med Case Rep"},{"key":"zoi221161r7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijid.2020.08.055","article-title":"A case report of newborn infant with severe COVID-19 in Mexico: detection of SARS-CoV-2 in human breast milk and stool.","volume":"100","author":"Hinojosa-Velasco","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"5","key":"zoi221161r8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-042093","article-title":"Neonatal MIS-C: managing the cytokine storm.","volume":"148","author":"Saha","year":"2021","journal-title":"Pediatrics"},{"issue":"2","key":"zoi221161r10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajog.2021.03.035","article-title":"Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy.","volume":"225","author":"Mithal","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"zoi221161r11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/MOP.0000000000000997","article-title":"Perinatal COVID-19: guideline development, implementation, and challenges.","volume":"33","author":"Flannery","year":"2021","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"zoi221161r12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/uog.v58.3","article-title":"Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.","volume":"58","author":"Bookstein Peretz","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"23","key":"zoi221161r13","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.2021.7563","article-title":"Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women.","volume":"325","author":"Collier","year":"2021","journal-title":"JAMA"},{"issue":"13","key":"zoi221161r14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150319","article-title":"Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine.","volume":"131","author":"Beharier","year":"2021","journal-title":"J Clin Invest"},{"issue":"11","key":"zoi221161r15","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.cmi.2021.08.004","article-title":"Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns.","volume":"27","author":"Cassaniti","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"zoi221161r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.10.006","article-title":"Newborns\u2019 passive humoral SARS-CoV-2 immunity following heterologous vaccination of the mother during pregnancy.","author":"Gloeckner","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"zoi221161r17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/AOG.0000000000004367","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibodies in neonatal cord blood after vaccination in pregnancy.","volume":"137","author":"Gill","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"49","key":"zoi221161r19","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd5709","article-title":"SARS-CoV-2 seroprevalence among parturient women in Philadelphia.","volume":"5","author":"Flannery","year":"2020","journal-title":"Sci Immunol"},{"issue":"6","key":"zoi221161r21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamapediatrics.2021.0038","article-title":"Assessment of maternal and neonatal cord blood SARS-CoV-2 antibodies and placental transfer ratios.","volume":"175","author":"Flannery","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"3","key":"zoi221161r22","doi-asserted-by":"publisher","first-page":"303.e1","DOI":"10.1016\/j.ajog.2021.03.023","article-title":"Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study.","volume":"225","author":"Gray","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"zoi221161r23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2021.100492","article-title":"Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy.","volume":"4","author":"Nir","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"11","key":"zoi221161r24","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/s41372-021-01216-1","article-title":"Titers of SARS CoV-2 antibodies in cord blood of neonates whose mothers contracted SARS CoV-2 (COVID-19) during pregnancy and in those whose mothers were vaccinated with mRNA to SARS CoV-2 during pregnancy.","volume":"41","author":"Kashani-Ligumsky","year":"2021","journal-title":"J Perinatol"},{"issue":"2","key":"zoi221161r25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMoa2115463","article-title":"Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines in U.S. veterans.","volume":"386","author":"Dickerman","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi221161r26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.15585\/mmwr.mm7107e3","article-title":"Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19-associated hospitalization in infants aged &lt;6 months\u201417 states, July 2021-January 2022.","volume":"71","author":"Halasa","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"zoi221161r27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4049\/immunohorizons.1700057","article-title":"The impact of IgG transplacental transfer on early life immunity.","volume":"2","author":"Fouda","year":"2018","journal-title":"Immunohorizons"},{"issue":"8","key":"zoi221161r28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/vaccines9080907","article-title":"Efficient maternal to neonate transfer of neutralizing antibodies after SARS-CoV-2 vaccination with BNT162b2: a case-report and discussion of the literature.","volume":"9","author":"Douxfils","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"zoi221161r29","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2021-0043","article-title":"COVID-19 mRNA vaccine in pregnancy and newborn passive immunization: a case report.","volume":"8","author":"Kassis","year":"2021","journal-title":"Future Sci OA"},{"key":"zoi221161r9","unstructured":"Centers for Disease Control and Prevention. CDC statement on pregnancy health advisory. Accessed November 23, 2021. https:\/\/www.cdc.gov\/media\/releases\/2021\/s0929-pregnancy-health-advisory.html?"},{"key":"zoi221161r18","doi-asserted-by":"crossref","unstructured":"Prabhu? M, Murphy? EA, Sukhu? AC, . Antibody response to SARS-CoV-2 mRNA vaccines in pregnant women and their neonates.? bioRxiv. Preprint posted online April 6, 2021. doi:10.1101\/2021.04.05.438524?","DOI":"10.1101\/2021.04.05.438524"},{"key":"zoi221161r20","unstructured":"National Institutes of Health. COVID-19 Treatment Guidelines. Clinical spectrum of SARS-CoV-2 infection. Accessed April 12, 2022. https:\/\/www.covid19treatmentguidelines.nih.gov\/overview\/clinical-spectrum\/?"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2798223\/flannery_2022_oi_221161_1667229250.41605.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T16:01:50Z","timestamp":1668009710000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2798223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.40993","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]}}}